Volume 28, Number 12—December 2022
Research Letter
Severe Fever with Thrombocytopenia Syndrome Virus Infection, Thailand, 2019–2020
Table
Characteristics and detection of severe fever with thrombocytopenia syndrome virus in 3 patients in Thailand, 2019–2020.
Category | Patient 1 | Patient 2 | Patient 3 |
---|---|---|---|
Age, y/sex |
60/M |
16/M |
52/F |
Location |
Bangkok |
Chachoengsao |
Bangkok |
Collection date |
2019 Nov 14 |
2020 May 10 |
2020 Oct 19 |
Clinical manifestations | |||
Temperature | 37.2°C | 40.6°C | 38.1°C |
Clinical signs and symptoms |
Myalgia, arthralgia, cough, nausea, vomiting, abdominal pain, diarrhea |
Myalgia |
Myalgia, arthralgia |
Laboratory findings (reference range) | |||
Leukocytes, cells/µL (4,100–10,900) | 1,790 | 900 | 2,770 |
Neutrophils, % (40–72) | 45 | 31 | 62 |
Lymphocytes, % (18–49) | 42 | 59 | 34 |
Platelets, cells/µL (140,000–400,000) | 107,000 | 45,000 | 121,000 |
Aspartate aminotransferase, U/L (<40) | Not done | 102 | 1,758 |
Alanine aminotransferase, U/L (<41) |
24 |
63 |
973 |
Pathogens tested for but not detected | Rickettsia/Orientia spp., influenza A/B | Rickettsia/Orientia spp., influenza A/B, Epstein-Barr, hepatitis B/C, SARS-CoV-2, malaria, Leptospira, Burkholderia pseudomallei | Rickettsia/Orientia spp., hepatitis A/B |
Page created: October 01, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.